Résumé
Laparoscopic sleeve gastrectomy (LSG) has become the most used bariatric surgery technique. The main purpose of this study was to assess the evolution of obesity related treatments. The second aim was to quantify the metabolic repercussions. Material and method: In this retrospective monocentric study, eligible patients were those who underwent LSG in 2014. We included patients who had pre-surgery medication reconciliation and had a 1 and 2 year-follow up. Pre-operative obesity related treatments were collected from medication reconciliation, and post-operative treatments were collected from hospitalization follow-up reports. Result: In 2014, 241 patients who underwent LSG were eligible, and 97 were included. The average number of treatments went from 1.9 (±1.9) to 1 (±0.9) one year after LSG and to 0.9 (±1.2) after 2 years. The most significant impact was on arterial hypertension and obstructive sleep apnea syndrome. No impact was shown on gastro-esophageal reflux (GERD). No significant improvements were shown after one year, at the exception of obstructive sleep apnea syndrome. Regarding vitamin insufficiency, 54.6% of the patients needed a supplementation in B9, 10.3% in B12, and 41.2% at least one other vitamin supplementation within 2 years. Conclusion: This study is consistent with present LSG data regarding comorbidities improvement. We were able to show that LSG is very efficient on all comorbidities at the exception of GERD. We also pointed out that vitamin supplementation is often needed, in spite of a good tolerance of LSG overall.
Titre traduit de la contribution | A one to two years follow up of treatments prescribed to obese patients taken care by sleeve gastrectomy |
---|---|
langue originale | Français |
Pages (de - à) | 135-141 |
Nombre de pages | 7 |
journal | Journal de Pharmacie Clinique |
Volume | 37 |
Numéro de publication | 3 |
Les DOIs | |
état | Publié - 1 sept. 2018 |
Modification externe | Oui |
mots-clés
- Comorbidities
- Nutritional deficiency
- Obesity
- Sleeve gastrectomy